NCT05810298

Effects of Yoga on Pulmonary Parameters, Posture, Body Awareness and Quality of Life Among Chronic Smokers

Effects of Pranayam (Voluntary Regulated Breathing) and Yogasana (Yoga Postures) on Posture, Pulmonary Parameters, Spine Flexibility, Body Awareness and Quality of Life Among Chronic Smokers
Yeditepe University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Asana Practice
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Yeditepe University
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Dec 22, 2022
End date
Mar 23, 2023
Enrollment
32 participants
Primary outcome

Fagerström Test for Nicotine Dependence,Thoracic Spine Range of Motion,Pulmonary Function Tests,Respiratory Muscle Strength,New York Posture Rating Chart,World Health Organization Quality of Life Assesment (WHOQOL-BREF),Body Awareness Questionnaire(BAQ)

Summary

The aim of this study is to examine the effects of practicing pranayam (voluntary regulated
 breathing) and yogasana (standing poses of yoga) with subject education on vital capacity,
 respiratory muscle strength, spinal flexibility, body awareness, quality of life and nicotine
 dependence of smokers and non-smokers.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05810298
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05810298 through Pure Global AI's free database. This phase not specified trial is sponsored by Yeditepe University and is currently Completed. The study focuses on Smoking. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.